Oren Gilad
CEO, President at Aprea Therapeutics, Inc. (APRE)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
—
Avg. 90-day return+12.0%
vs. S&P 500+8.5%
Beat the market100%
Paper profit on buys−$8K
Total bought / sold$25K / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Feb 2SEC | APREAprea Therapeutics, Inc. | Buy | 28,100373,720 held (+8%) | $0.89 | $25K | -32.1% |
- Buy
CEO, President Oren Gilad bought $25K of APRE at $0.89 — first open-market purchase in our records.